Author

admin

Browsing

Survey also validates significant mineralization and unlocks new targets

Highlights

  • Direct correlation with mineralization : The modeled geophysical plates explain the presence of semi-massive to massive sulfides intersected in holes TOM-25-009 to TOM-25-015.
  • Priority target BER-14C : Identification of a major 160 x 300 m plate, open at depth and to the northeast , suggesting the presence of a significant massive sulfide lens near drill hole TOM-25-014.
  • Confirmation of Berrigan Deep : The TOM-25-015 drill hole perfectly intersects the southeast extension of the BER-14C plate, validating the continuity of the mineralized system at a depth of over 450 metres .

TomaGold Corporation (TSXV: LOT,OTC:TOGOF; OTCPK: TOGOF) (‘ TomaGold ‘ or the ‘ Company ‘) is pleased to announce the interpretation results of the borehole electromagnetic (BHEM) survey completed on its Berrigan Mine project, located in the Chibougamau mining camp.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205830419/en/

Figure 1: TomaGold’s borehole EM survey confirms Berrigan Deep Zone

The survey, conducted by Abitibi Geophysics, modeled ten conductive plates of varying orientation and size that not only corroborate the high-grade intersections already announced, but also indicate significant extension potential, particularly with the discovery of the Berrigan Deep zone.

David Grondin, President and CEO of TomaGold, stated: ‘The geophysics confirm what our drill cores indicated: Berrigan Mine sits on a large-scale mineralized system. The BER-14C plate, in particular, extends the mineralization signature of holes TOM-25-014 and TOM-25-015 with a vector pointing to an even more conductive zone to the northeast.’

Technical analysis of the plates

The survey uses Terrascope PRO5U transmitters (up to 15 kW) powered by a Wildcat generator to transmit a bipolar signal in a 530 x 560 m surface loop with a current of 30 A. The borehole measurements are taken at frequencies of 5 Hz and 1 Hz using a GPS-synchronized DigiAtlantis triaxial probe, which captures the components of the magnetic field. Finally, the data is processed and modeled using specialized Maxwell and Oasis Montaj software, with the conductive plates shown in green in Figure 1.

Table 1: Comparative analyses Drilling/BHEM

Sector / Drill hole

Intersection (base interval)

Geophysical plate

Conductance (S)

Plate dimensions (m)

Berrigan Deep (TOM-25-015)

1.98% Zn, 0.82 Au g/t and 3.21 Ag g/t over 98.50 m

BER-14C

5000

160×300

West Extension (TOM-25-014)

4.55% Zn, 4.94 Au g/t and 56.44 Ag g/t over 2.10 m

TOM-25-014_B

5000

85×90

Main Zone (TOM-25-009)

1.40% Zn, 1.12 Au g/t and 7.55 Ag g/t over 48.05 m

TOM-25-009_C

4000

40×40

North Zone (TOM-25-012/13)

Results pending

TOM-25-12+13_A

1900

70×220

Source: Rapport technique d’Abitibi Géophysique (25QC084-BT TomaGold, Berrigan, BHEM, 2026)

Note: TomaGold has reverted to reporting elemental assay results rather than metal equivalent grades. The mineralization style encountered at Berrigan Mine differs from typical sulphide deposits in the surrounding area, including Scott Lake, Lemoine and Mattagami, as well as outside the immediate region such as Normétal, Rouyn-Noranda and Timmins. As a result, metallurgical recovery assumptions remain uncertain at this stage and cannot currently support the use of metal equivalent calculations.

Next Steps

TomaGold plans to:

  1. Drill three new holes (TOM-26-016 to TOM-26-018) to test the northeast and depth extensions of the BER-14C conductive plate.
  2. Conduct additional follow-up drilling to extend holes TOM-25-010, 011, and 013 with the goal of reaching modeled targets, and drill a corner hole from hole TOM-25-015.
  3. Conduct a low-frequency surface electromagnetic (EM) survey to better define the thickness, continuity, and lateral extent of the mineralized system.

About the Berrigan Mine Project
The Berrigan Mine property consists of 16 claims totalling 483 hectares located 4 km north-northwest of the town of Chibougamau. TomaGold has an option to acquire 100% of the property from Chibougamau Independent Mines Inc.

The property has been the subject of more than one historical estimate. Met-Chem Canada Inc. prepared the most recent of these in April 2001 in a report titled: ‘Pre-feasibility study: Etude Conceptuelle, Projects Berrigan and Tortigny’ by Chuinard et al. In the report, a resource estimate completed using polygonal estimation techniques stated 1.39 Mt grading 3.17% Zn and 1.77 g/t Au on the main Berrigan Mine zone. No resource classifications were given for the resource (GM61359).

The mineral resource estimate presented above is historical in nature and was not prepared in accordance with National Instrument 43-101 standards. Accordingly, the reader is cautioned not to rely on this estimate, as the Company is not treating the estimate as a current mineral resource. The qualified person has not done sufficient work to make the resource current. Substantial data compilation, verification, and, potentially, additional drilling and resampling would be required by a qualified person before the historical estimate could be classified as a current mineral resource. There can be no assurance that any portion of the historical mineral resource will ultimately be confirmed or demonstrated to be economically viable. For further information regarding the Berrigan Mine Project, please consult the press release dated September 13, 2023 .

Technical Disclosure
The drilling program was managed by Explo-Logik of Val-d’Or, Québec. Drill core was split in half, with one half submitted to AGAT Laboratories at Val-d’Or for analysis. Gold was analyzed by fire assay (50 g) with atomic absorption finish, while base metals were analyzed by four-acid digestion with ICP-OES finish. Samples with gold grades greater than 10 g/t are reprocessed using metallic screening with a 106 µm cutoff. The processed material is split and analyzed by fire assay with ICP-OES finish to extinction. A separate split is prepared to independently analyze mineralized intervals with a target grade greater than 1.00% Cu-Zn using a Na₂O₂ fusion with ICP-OES or ICP-MS finish. Sample preparation duplicates, certified reference standards, and blanks are inserted into the sample stream.

The technical content of this press release has been reviewed and approved by Jean Lafleur, P.Geo., Vice President of Exploration of the Company, and Suzie Tremblay, P.Geo., Vice President of Operations at Explo-Logik Inc. and a consultant to TomaGold, each acting as a Qualified Person under National Instrument 43-101.

About TomaGold
TomaGold Corp. (TSXV: LOT,OTC:TOGOF, OTCPK: TOGOF) is a Canadian junior mining company focused on the acquisition, exploration, and development of high-potential precious and base metal projects, with a primary focus on gold and copper in Québec and Ontario. The Company’s core assets are located in the Chibougamau Mining Camp in northern Québec, where it owns the Obalski gold-copper-silver project and holds options to acquire 12 additional properties, including the Berrigan Mine, Radar, David, and Dufault projects. TomaGold also holds a 24.5% joint venture interest in the Baird gold property near the Red Lake Mining Camp in Ontario. In addition, the Company has lithium and rare earth element (REE) projects in the James Bay region, strategically positioned near significant recent discoveries.

Follow TomaGold:

WhatsApp: https://www.whatsapp.com/channel/0029Vb79qG6LdQeiiErI1e27
LinkedIn: https://www.linkedin.com/company/tomagold-corporation
Facebook: https://www.facebook.com/TomaGoldCorporation
Instagram: https://www.instagram.com/tomagoldcorp
X: https://x.com/tomagoldcorp

Cautionary Statement on Forward-Looking Information
This news release includes certain statements that may be deemed ‘forward-looking statements’. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words ‘expects’, ‘plans’, ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘projects’, ‘potential’ and similar expressions, or that events or conditions ‘will’, ‘would’, ‘may’, ‘could’ or ‘should’ occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include the potential results of exploration and drilling activities, market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates, opinions, or other factors should change.

Neither TSX Venture Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260205830419/en/

David Grondin
President and Chief Executive Officer
(514) 583-3490
www.tomagoldcorp.com

News Provided by Business Wire via QuoteMedia

This post appeared first on investingnews.com

Alleged fraud schemes plaguing Minnesota’s social services systems have elevated scrutiny surrounding childcare centers. 

But fraud can be challenging to identify for states – especially when agencies are using outdated systems that make it difficult to spot trends and red flags that could point to potential fraud, according to Chris Bennett, the CEO and founder of a Wonderschool, a platform that provides technology support to child care providers and states. 

‘When you have all this data living in different place, it’s really difficult for a state to identify where there is risk and where there is fraud,’ Bennett recently told Fox News Digital during an interview. ‘Additionally, a lot of states are using pen and paper still to collect information. So it makes it really difficult for an administrator and the administrator’s team to go through all of that and make sure that they’re keeping up with things on a regular basis.’

Streamlining systems is key to identifying any atypical trends in billing behavior and attendance data that could point to fraud, Bennett said.

‘The best practice is moving to a modern system, moving to a system where all of the data is in one place and it’s all connected,’ Bennett said. ‘So you can use that to identify risk, flag unusual patterns early, and then have humans go and investigate. Oversight should support child care providers, not punish them.’ 

To help do this, Bennett spearheaded Wonderschool Oversight in January – building upon Wonderschool’s existing partnerships with states including Florida, Michigan and Illinois – that aims to centralize state agencies’ program data to evaluate enrollment, attendance, billing and licensing information in the same place. 

Having this information in one spot allows for Wonderschool Oversight to flag unusual patterns that could require human review, Bennett said.

‘For example, we can analyze daily attendance data to flag cases where billed attendance exceeds recorded attendance,’ Bennett said. ‘We review billing behavior for anomalies — such as sudden spikes in billing corrections — which can indicate potential issues. Or, in another example, we compare reported attendance against licensed capacity, age-band limits, and required staffing ratios to surface possible regulatory or safety violations.’ 

Childcare fraud has come under a microscope after right-wing influencer Nick Shirley shared a video in December detailing alleged fraud involving Minnesota childcare and learning centers. 

The Department of Health and Human Services (HHS) announced in January that it would put a hold on access to some federal childcare and family assistance funding for five states – including Minnesota – due to ‘serious concerns about widespread fraud and misuse of taxpayer dollars in state-administered programs.’ 

Days later, a federal judge temporarily blocked the Trump administration from halting the funding freeze for at least two weeks. Fox News Digital reached out to HHS for comment. 

That’s not the only alleged fraud scheme the state is facing. Lawmakers have spearheaded investigations into Minnesota’s alleged ‘Feeding Our Future’ $250 million fraud scheme that allegedly targeted a children’s nutrition program the Department of Agriculture funded and that Minnesota oversaw during the COVID-19 pandemic.

At least 77 people have been charged in that scheme, which took advantage of the U.S. Department of Agriculture’s decision to waive certain Federal Child Nutrition Program requirements.

Likewise, another alleged fraud scheme in the state stems from the Housing Stability Services Program, which allegedly offered Medicaid coverage for housing stabilization services in an attempt to help those with disabilities, mental illnesses and substance-use disorders receive housing.

This post appeared first on FOX NEWS

Sen. Bernie Sanders, I-Vt., who criss-crossed the country last year on a ‘Fight Oligarchy’ tour with Rep. Alexandria Ocasio-Cortez, D-N.Y., spent over $550,000 in 2025 on private jet travel for himself using campaign funds, a Fox News Digital review of Federal Election Commission (FEC) filings found.

The majority of the spending came in the first two quarters, which cover up until July. That is also when Sanders and AOC had the majority of their tour stops across the country. 

In April, between stops on the tour, Fox News Digital exclusively obtained a photo of Sanders boarding a luxury Bombardier Challenger private jet at the Meadows Field Airport in Bakersfield, California. The source also indicated that they had spotted the New York congresswoman boarding the private jet as well. 

The pair were subsequently also seen in footage obtained by Fox News Digital exiting the plane in Sacramento later that evening, near where the self-identified Democratic socialists hosted a second rally in one day.  

The Bombardier Challenger private jet the pair flew on was operated by Ventura Air Services, which touts ‘one of the widest cabins of any business jet available today’ and provides ‘superior cabin comfort for its passengers.’ According to their website, the private jet can cost up to $15,000 an hour.

In 2025, according to Sanders’ FEC filings, he spent at least $354,000 in campaign funds to pay for private jet services through Ventura Jets. The other private jet companies Sanders spent campaign funds on included N-Jet and Cirrus Aviation Services. 

According to N-Jet’s website, the company pieds itself on their ‘personal touch,’ adding that customers will ‘arrive in style with your luxury, comfort, and safety always top of mind.’

Sanders, who has been a vocal supporter of the Green New Deal, the aggressive climate change policy targeting carbon emissions and fossil fuel production, and has called climate change an ‘existential threat’ to the world, was pressed about his private jet use last year, prompting him to tell Fox News’ ‘Special Report’ host Bret Baier that ‘that’s the only way to get around.’

‘You run a campaign, and you do three or four or five rallies in a week. [It is] the only way you can get around to talk to 30,000 people. You think I’m gonna be sitting on a waiting line at United…while 30, 000 people are waiting?’ Sanders said.

‘That’s the only way to get around. No apologies for that. That’s what campaign travel is about. We’ve done it in the past. We’re gonna do it in future.’

Sanders has a long history of using private jets on the campaign trail. During his failed 2020 presidential campaign, the Sanders campaign spent over $1.9 million on private jets, including Apollo Jets and the Advanced Aviation Team, a Virginia-based private jet company.

Private jets have faced the ire of Sanders and Ocasio-Cortez’s fellow climate activists. According to the 2021 Transport and Environment report, private jets are up to 14 times more polluting than commercial planes.

‘For real, how many private jets do these CEOs need? It is insatiable. It is unacceptable,’ Ocasio-Cortez said in 2023, in one example of the New York congresswoman herself railing against private jets. 

Fox News Digital reached out to Sanders’ office and his campaign for comment on the spending but did not receive a response in time for publication.

‘You don’t expect a socialist to fly commercial do you?’ quipped conservative political communications consultant Matt Gorman. ‘There’s no bigger hypocrite than the liberal who chastises us for eating meat and using gas stoves, yet flies in private jets.’ 

In addition to Sanders’ hefty private jet spending that came during his tour with AOC, the New York Democratic socialist also spent big sums of campaign dollars at luxury and ’boutique’ hotels in states where the pair held their ‘Fight Oligarchy’ Tour. 

For example, AOC’s campaign paidThe Leo Kent Hotel, a boutique high-rise in Tucson, $3,165.76, around the time of a ‘Fight Oligarchy’ rally that was held there, according to an FEC filing from April 25. In 2025, AOC also spent thousands at luxury hotels like the Asher Adams Hotel in Salt Lake City, the Hotel Vermont in Burlington, The Langham-Huntington hotel in Pasadena, Calif., Hotel El Convento in San Juan, Puerto Rico, the Lansdowne Resort & Spa in rural Virginia, and more. 

Fox News Digital asked representatives for AOC if the congresswoman felt like she needed to explain her more than $53,000 in campaign spending on upscale hotels across the country in 2025, but did not receive a response.

Fox News Digital’s Cameron Cawthorne, Andrew Mark Miller and Deirdre Heavey (formerly) contributed to this report.

This post appeared first on FOX NEWS

Nicki Minaj, who has recently been a vocal critic of California Gov. Gavin Newsom, accused him in a new interview of trying to be like President Donald Trump, referring to recent social media posts of the governor’s that emulate the president’s frank style.

‘With Newscum, it’s the fact that with everything you said, but then having the audacity to be playing on Twitter, obsessed with Trump, trying to be Trump, trying to be funny when it’s not and then wanting to roll around in the mud with female rappers or whomever and completely missing the plot,’ Minaj told Katie Miller on her podcast this week.

Many of Minaj’s online attacks have been over the governor’s support of transgender children.

‘Imagine being the guy running on wanting to see trans kids,’ Minaj wrote on social media late last year. ‘Not even a trans ADULT would run on that. Normal adults wake up & think they want to see HEALTHY, SAFE, HAPPY kids. Not Gav. The Gav Nots. GavOUT. Send in the next guy, I’m bored.’

She suggested to Miller that Newsom would be better off not trying to compete with Trump.

‘But President Trump is already the president, get it?’ she said as if speaking directly to Newsom. ‘He’s already done it twice. He’s won. Good. OK. Meanwhile, you are embarking on what — a journey that will end up being a big huge failure for him.’

The ‘Tukoh Taka’ singer said the governor still doesn’t ‘seem to grasp the fact that these jokes that you’re making are only funny to your assistant, you know, the weirdo little guy that calls Black women stupid h— and stuff.’

Newsom’s assistant responded to one of Minaj’s slams on social media last year by posting a picture of a Nicki Minaj T-shirt in the trash. He captioned the image: ‘Stupid H–,’ a reference to her 2012 song of the same name.

She claimed that ‘no one cares’ about Newsom’s rhetoric online, ‘and he’s making a fool out of himself like when he went all the way to another country to speak ill of the country and the president. We would never want someone like that to be our president. Americans are so big on loyalty and that just showed us all you do not have a loyal bone in your body and no one is going to vote for you.’

Newsom spoke at the World Economic Forum in Davos, Switzerland, last month, expressing his concerns that ‘freedom of expression, freedom of assembly, freedom of speech’ are all under attack because of the Trump administration.

‘They’re censoring historical facts, they’re rewriting history,’ he added, also claiming that the administration had canceled an earlier event the governor was supposed to speak at.

Minaj said Newsom failed to respond to her when she asked for his office’s help ‘on Twitter about swatting calls that were happening that were clearly a part of their extended smear campaign. And he completely ignored it, right? And next thing you know, he’s on there flapping his gums about female rap stuff and trying to get in women’s business. So I had to. I had to show him who’s boss on Twitter.’

Newsom has only responded to her tirade of social media attacks once.

In December, he posted a mashup of videos and images of Trump, including with Jeffrey Epstein, set to Meghan Thee Stallion’s Minaj diss track ‘HISS.’

Fox News Digital has reached out to Newsom’s office for comment.

This post appeared first on FOX NEWS

A pro-life group is releasing a new report claiming abortions have continued to rise nationwide since 2020 because of a Biden administration FDA policy that allows abortion pills to be prescribed via telehealth and shipped by mail — a move the group says the Trump administration could reverse.

In a report obtained by Fox News Digital, the Restoration of America Foundation (ROAF) argues that a COVID-era FDA policy under former President Joe Biden is driving an estimated more than 500 mail-order chemical abortions per day, citing data from Guttmacher and WeCount.

The data also shows that chemical abortions now account for the majority of abortions, making up about 63% in 2023, a jump from 39% in 2017.

The report also estimates that there were roughly 170,000 additional abortions in 2024 than would have happened if the abortion rate had remained at 2019 levels.

‘Since hitting a low in 2017, the national abortion rate has seen a persistent and troubling climb,’ the report states. ‘In 2019, the last full year that abortion by mail was clearly illegal, there were an estimated 916,460 abortions. Using our estimate for 2024, the overall growth in abortion from 2019 to 2024 was 22 percent. Over the same window, the U.S. population grew by just 2.9 percent. Had the abortion rate remained steady from 2019, there would have been 171,103 fewer abortions in 2024.’

The findings show abortion-by-mail made up roughly one in four abortions in the U.S. in the first half of 2025.

WeCount data cited in the report also shows an estimated 244,590 do-it-yourself abortions were facilitated by telehealth in 2024, including more than 120,000 pills sent into states where abortion was restricted or banned after the Supreme Court overturned Roe V. Wade in 2022, giving the power to make abortion laws back to the states.

The Biden administration policy removed safety standards that required women to see a doctor to be prescribed mifepristone, allowing it to be prescribed through telehealth and sent by mail. The report argues that the FDA under Biden justified the change using limited studies and adverse-event data, despite most mandatory reporting requirements for mifepristone complications being removed in 2016 under the Obama administration. A research paper in 2021 additionally compared adverse-event data with Planned Parenthood data and concluded that the system is ‘inadequate’ to evaluate the safety of mifepristone abortions.

‘People are calling up and saying whatever they need to say to get the drug in the mail,’ ROAF CEO Doug Truax said in an interview with Fox News Digital. ‘The point that we’re making is that abortions are on the rise dramatically. 874,000 in 2023, up to 1.1 million in 2024. Then on this trajectory, by the time President Trump leaves office, it’d be about 1.4 million a year. And so it’s largely driven by the drugs going out in the mail.’

‘There’s about 150 women a day that are being seriously harmed by this drug,’ Truax continued. ‘So we need to get them to go see the doctor. The doctor needs to verify where they’re at with the pregnancy. Obviously, if it’s an ectopic pregnancy, it means they could take this drug, and they could die from it, which has happened. But there are all kinds of sepsis and rupturing and hemorrhaging and everything going on with this drug.’

‘So there are two angles to this. We’re very pro-life over here. We want to go to zero abortions in the country. But the other angle is that this is a women’s health issue. So we need to decrease the number of abortions, and we need to basically save women from being harmed by this,’ he added.

Truax also noted that states with higher populations are receiving the most abortion pills through the mail and that Democrat-led states have enacted shield laws preventing GOP-led states from taking legal action against providers.

‘For instance, Texas, they don’t have abortion anymore, but they sure do,’ he said. ‘People think it’s down to zero. It’s not at all. It’s about where it was. So you have all these abortionists in, to name a few, Massachusetts and California. There’s dispensing organizations now around the country and around the globe that will mail these things out. They’re very active getting these abortion drugs into states that said, ‘we don’t want abortion here.”

The FDA continues to keep the in-person dispensing requirement for mifepristone suspended — a safety rule that had been in place for roughly 20 years before Biden’s FDA permanently removed it following a COVID-era suspension.

The policy was met with legal challenges under the previous administration, but the Supreme Court allowed it to remain in effect after ruling that the plaintiffs lacked standing. The Fifth Circuit Court of Appeals had ruled the FDA’s action under Biden was likely ‘arbitrary and capricious’ under the Administrative Procedure Act.

Truax said that the Trump administration has the authority to nix the policy, and urged the federal government to do so.

‘I think that from a political standpoint, they’d rather not talk about it. But our point is, from a political standpoint, it’s going to start hurting. Pro-life Americans are really grateful to the president for the Supreme Court that we have, they got Roe thrown out, as it should have been a long time ago. But there’s more work to be done. We’re grateful for defunding Planned Parenthood. That’s great for a year. But the bottom line is, if the number of abortions is actually going up and there’s a step you could take to stop it, we got to do that,’ he said.

‘There’s a massive number of pro-life Americans that are base supporters of the president who may say, ‘wait a minute, we’ve been in power for this entire time and the number of abortions keeps going up, and we could have stopped it,” he added.

Republican lawmakers on Capitol Hill and state officials have been calling on the Trump administration to take action.

Last summer, more than 20 attorneys general urged Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary to complete a safety review of mifepristone and consider reinstating safeguards or removing the drug from the market. Kennedy and Makary vowed to conduct a new review of the safety of the drug, but they have not released a timeline for the results.

‘President Trump, Secretary Kennedy, and Commissioner Makary already have the tools at their disposal to reverse the legally and scientifically dubious decisions of the Biden Administration’s FDA and to reinstate the in-person dispensing requirement. The Trump Administration must act swiftly to restore commonsense medical safeguards to the chemical abortion pill,’ the ROAF report says.

This post appeared first on FOX NEWS

Venezuelan official Alex Saab, a former businessman and close ally of captured former Venezuelan President Nicolás Maduro, was arrested in the Latin American country on Wednesday as part of a joint operation between the U.S. and Venezuela, according to a U.S. law enforcement official.

Saab, 54, who had previously been held in the U.S., is expected to be extradited to the U.S. in the coming days, the U.S. official told Reuters.

A lawyer for Saab, Luigi Giuliano, was cited in the Colombian newspaper El Espectador later on Wednesday, denying the arrest as ‘fake news.’ Journalists aligned with Venezuela’s government also made social media posts denying that Saab had been arrested.

Giuliano told Venezuelan news site TalCual that Saab may make an appearance to refute the arrest allegations himself but was consulting with the government about what had happened.

Venezuela’s top lawmaker, Jorge Rodríguez, did not confirm or deny the reports during a press conference, saying he had no information concerning the possible arrest.

This comes after the U.S. operation to attack Venezuela and arrest Maduro, and the Trump administration’s subsequent seizing of oil tankers from the country.

Saab’s arrest would suggest a new level of collaboration between U.S. and Venezuelan authorities under the government of interim President Delcy Rodríguez, Maduro’s former deputy, who currently controls Venezuela’s law enforcement agencies and actions.

The U.S. official highlighted the significance of Rodriguez’s cooperation in the joint operation.

Raul Gorrin, the head of Venezuela’s Globovision TV network, was also arrested in the operation, the official said.

Saab, who was born in Colombia, was previously detained in the African nation of Cape Verde in 2020 and held in the U.S. for more than three years on bribery charges. He was eventually granted clemency in exchange for the release of Americans held in Venezuela.

Before he was granted clemency, U.S. officials had charged Saab with taking around $350 million out of Venezuela through the U.S. as part of a bribery scheme connected to Venezuela’s state-controlled exchange rate.

Saab denied the allegations and appealed to have the charges dismissed on grounds of diplomatic immunity. An appeals court had not ruled on Saab’s appeal by the time the prisoner swap went through.

When he returned to Venezuela at the end of 2023, Maduro praised Saab’s loyalty to the country’s socialist revolution and called him a national hero.

Maduro later appointed Saab as industry minister, a position he held until last month, when he was dismissed by Rodriguez following the arrest of the country’s former leader.

Reuters contributed to this report.

This post appeared first on FOX NEWS

For at least two decades, former Amazon executive Dave Clark ended his work week the same way: a standing Friday date night with his wife, Leigh Anne.

Over dinner, the Clarks would talk through the “peak and pit” of their weeks. The ritual often revolved around Amazon, where Clark played a central role in building the logistics infrastructure that helped launch the e-commerce era.

During those years, Leigh Anne was a sounding board for her husband. In the process, she had a front-row seat to Amazon’s growth from what she called “a baby to a behemoth.”

By the time Clark left Amazon in 2022, he was CEO of the Worldwide Consumer division and one of billionaire founder Jeff Bezos’ top lieutenants.

Dave Clark at Auger headquarters Monday.David Jaewon Oh for NBC News

But these days, Fridays for the Clarks look very different.

Their dinner date has morphed into afternoon cocktails — a bourbon with Diet Coke for her and a Manhattan for him. And the conversation isn’t focused on Amazon anymore. It’s about Auger, the supply-chain startup they run together.

In their first joint interview from Auger’s Seattle office, the Clarks described how their marriage and complementary skill sets are shaping the company.

“We’ve been together for so long that we kind of just read each other’s minds,” Leigh Anne said. Working together, she said, “felt like a natural fit.”

This post appeared first on NBC NEWS

The U.S. Equal Employment Opportunity Commission said Wednesday that it is investigating Nike for allegedly discriminating against white workers.

The agency that polices discrimination in the workplace filed an action in federal court in Missouri to compel the publicly traded athletic shoe and apparel giant to produce information in response to a subpoena the agency served on the company last fall, according to court filings reviewed by NBC News.

The EEOC said it was investigating allegations that the company’s mentorship and training programs and its personnel decisions gave nonwhite employees preferential treatment that amounts, according to the agency, to discrimination against white workers.

Nike is the world’s largest sportswear and apparel company, with nearly 80,000 employees and revenues of around $51.4 billion in 2024.

The allegations were not made by workers at Nike who believed they had been the targets of unfair treatment, however, as is typically the case in EEOC investigations.

Instead, the court filings show that this case stems from a commissioner’s charge brought by then-commissioner Andrea Lucas herself in May 2024, and based on publicly available information such as Nike’s own annual “Impact Reports” and information on its public website.

The EEOC’s request that a judge enforce the subpoena is the latest instance of the Trump administration using a federal agency that is typically charged with preventing and responding to discrimination against nonwhite Americans, and deploying it instead to protect what it says are the underrepresented interests of white people.

Nike has objected in court to many of the EEOC’s demands to documents over the last several months, arguing that they are vague, overly broad, and seek information dating back to well before the period in question.

“This feels like a surprising and unusual escalation,” a Nike spokesperson said. “We have had extensive, good-faith participation in an EEOC inquiry into our personnel practices, programs, and decisions and have had ongoing efforts to provide information and engage constructively with the agency.”

The spokesperson added that Nike has shared “thousands of pages of information and detailed written responses” in connection with the agency’s inquiry and said the company is in the “process of providing additional information.” Nike will respond to the agency’s petition, the spokesperson said.

Lucas was appointed chair of the EEOC by President Donald Trump in November 2025 after serving as a commissioner since 2020, when the president nominated Lucas to the agency.

The agency said it filed the subpoena enforcement action after “first attempting to obtain voluntary compliance with its investigative requests.”

This post appeared first on NBC NEWS

Elon Musk’s Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers.

Neuralink has drawn interest to the brain computer interface (BCI) sector with its N1 implant, which is undergoing human trials in patients with spinal cord injuries (SCIs) and ALS.

Musk’s company is far from the only one developing BCI tech to assist users with conditions such as SCIs, ALS and neurological disorders.

‘The number of new firms entering the space and the amount of venture funding being distributed to startups surpasses any other product category we have seen in the 25 years we have been covering the neurotechnology industry,’ Neurotech Reports stated in June 2025.

As Neuralink continues to make strides, investors are wondering how to get a piece of the action by investing in the neurotechnology venture.

Because it is privately held, Neuralink stock isn’t accessible to the average person — but that doesn’t mean it’s impossible to get exposure to this future-looking medical research company. Read on to learn how to participate in the growth of this exciting business, and other BCI firms you can invest in.

In this article

    What is Neuralink?

    Neuralink is a neurotechnology startup that was founded in 2016 by Tesla (NASDAQ:TSLA) CEO Musk and a team of eight scientists and engineers in 2016.

    It was first reported on in 2017, and two years later, in June 2019, the company held and streamed its public launch event to showcase the technology it is developing: an innovative brain-computer interface.

    Instead of using traditional electrodes, which, according to a company whitepaper, can be bulky and damaging to brain tissue, Neuralink’s BCI uses “ultra-thin threads” that are implanted into the brain using a robotic device that resembles a sewing machine. Once implanted, the electrodes develop a BCI, stimulating the brain and monitoring activity, and the threads connect to a custom-designed chip that can read data from groups of neurons.

    Musk announced the coin-sized Telepathy chip, with over 1,000 electrodes 20 times finer than hair, in January 2024.

    Potential uses of BCI technology include helping paralyzed individuals regain control of their limbs and restoring vision. Musk told his audience during Neuralink’s 2019 launch event that this technology could have a wide range of applications in medicine, such as restoring sensory and motor function in people with spinal cord injuries or neurological disorders. Additionally, an early goal of development is translating neuron signals into computer commands, which would allow humans to control devices like computers and smartphones with their brainwaves.

    Musk has claimed that BCI could even facilitate direct communication between humans and machines, although some members of the neuroscientific community are skeptical.

    Other experts have suggested that Neuralink’s work is not necessarily novel, as Dr. Jason Shepherd, an associate professor of neurobiology at the University of Utah, told Business Insider in 2020. “All the technology that he showed has been already developed in some way or form,’ he said. ‘Essentially, what they’ve done is just package it into a nice little form that then sends data wirelessly.”

    Other experts in the field have ethical concerns about how Neuralink is conducting its clinical trials and the broader implications of disregarding established standards.

    “If you decide to play with fire in a house, you increase the risk threshold not only of yourself but of the whole house,” Marcello Ienca, a professor of ethics of AI and neuroscience at Technical University of Munich, told Forbes in 2024. “My fear is that Neuralink’s disregard for the ethical aspects of their technology may cause a backfire effect for the entire neurotechnology community.”

    How much is Neuralink worth?

    Neuralink was valued at around US$9.7 billion as of June 2025, but as a privately held business, much of its financial information is kept under wraps. That said, US Securities and Exchange Commission (SEC) documents containing information about its funding rounds provide some insight.

    The earliest came in 2017, when the company raised US$27 million out of a planned US$100 million in a Series A funding round. In April 2019, SEC filings show the company acquired US$39 million out of a planned US$51 million in a Series B funding round. A limited amount of information has been made available to the public, and the identities of the investors have not been publicly disclosed. However, some news outlets have speculated that funding could have come from a combination of venture capitalists, or from Musk himself and the Neuralink team.

    In 2021, Neuralink received what was then its largest amount of money to date, raising US$205 million in a funding round led by tech investment firm Vy Capital. Other participants included Google Ventures, the venture capital arm of Alphabet (NASDAQ:GOOGL); OpenAI CEO Sam Altman; Fred Ehrsam, co-founder of Paradigm and Coinbase Global (NASDAQ:COIN); and Ken Howery, co-founder of PayPal Holdings (NASDAQ:PYPL) and Founders Fund.

    In May 2023, as Neuralink faced public backlash over accusations of animal mistreatment, it received clearance from the US Food and Drug Administration (FDA) to run the first human trial of its brain implant. Just months later, in August, Neuralink closed a US$280 million funding round led by Founders Fund. The filing was amended in November 2023 to reflect an additional US$43 million, bringing the total to US$323 million.

    Most recently, the company announced the closure of a US$650 million Series E funding round in June 2025.

    Is Neuralink approved for human trials?

    In May 2023, Neuralink received clearance from the US Food and Drug Administration (FDA) to run the first human trials of its brain implant. The company opened a patient registry in early 2023 that allowed people who had at least one of a qualifying list of conditions to volunteer for upcoming clinical trials. It is also approved for human trials in Canada, Great Britain and the UAE.

    The first US study, dubbed PRIME — Precise Robotically Implanted Brain-Computer Interface — is specifically focused on patients with cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS). It has an estimated primary completion date of January 2026 and is estimated to be fully completed by January 2031.

    The study’s first participant, a patient with quadriplegia, received the implant on January 28, 2024; Musk reported a quick recovery and ‘promising neuron spike detection’ the following day.

    A month later, Musk said the patient, who is named Noland Arbaugh, could control a cursor mentally. Arbaugh shared 100-day positives in May 2024, calling it a success over prior tech. One of the largest benefits is that it allows him to operate his computer and other devices lying down, while he needed assistance for setup and repositioning with prior devices. He explained that the change gives him more freedom to live on his own time.

    The study’s next two participants were a patient who became paralyzed following a spinal cord injury from a diving accident and another who lost use of his limbs to ALS. The company issued an update on their progress in February 2025, with all three patients touting positive changes following the procedure.

    As of January 2026, Neuralink has now implanted devices in 21 trial participants across the US, Canada, the UK and the UAE.

    The UAE-PRIME trial began recruiting in May 2025 via the Cleveland Clinic Abu Dhabi, while the GB-PRIME study launched in Great Britain two months later.

    Neuralink is also conducting the CONVOY study in the US, announced in November 2024, testing the use of the implant to control an investigational assistive robotic arm. It is open to participants of the PRIME study.

    Meanwhile, the company received FDA breakthrough device designation for Blindsight, a capability being developed to generate visual perception by activating brain areas responsible for visual function, as well as for its speech restoration technology, in 2024 and 2025, respectively. Blindsight trials aimed at restoring vision for the blind are reportedly planned to begin soon in the UAE.

    Looking ahead, Musk says the company will begin high-volume chip production in 2026. In a January update, Neuralink shared plans to improve the implant, including raising electrodes from 1,000 to 3,000. It is also investigating a change to the surgical procedure that would reduce invasiveness by inserting the implant’s threads through the dura mater, the brain’s tough outer membrane.

    How to invest in Neuralink?

    With Neuralink continuing to move forward, how can investors get a piece of this up-and-coming technology?

    The firm has yet to go public, so purchasing Neuralink stock is not an option for many investors. However, there are still ways for investors to potentially profit from Neuralink’s growth before it goes public.

    The vast majority of Neuralink’s funding has come from venture capitalists and a handful of billion-dollar companies. Investors can gain indirect exposure to Neuralink before its IPO by buying publicly traded companies that have invested in the company. This includes Alphabet (NASDAQ:GOOGL), which has funded Neuralink via its subsidiary Google Ventures. This strategy captures potential upside from Neuralink’s growth.

    Those who qualify as accredited investors could also potentially invest in a Neuralink funding round. According to the SEC, an accredited investor must have a net worth of at least US$1 million, not including the value of their primary residence, or an annual income of at least US$200,000 for individuals and US$300,000 for married couples. There must also be a reasonable expectation of the same level of income in the year of filing.

    Individuals can also qualify as accredited investors if they are investment professionals in good standing. In that case, the SEC’s guidelines indicate that they need to hold either a general securities representative license, an investment advisor representative license or a private securities offerings representative license.

    Entities like banks, insurance companies or investment firms with total assets of at least US$5 million may also qualify as accredited investors. Certain types of entities, such as private business companies and small business investment companies, may be exempt from the standard asset value requirements for accredited investor status.

    It’s also worth noting that Neuralink is just one of several companies currently working on developing BCI technology:

      The potential for BCI to impact various industries such as robotics, medicine and biotech has generated a growing amount of interest and excitement. Additionally, heightened interest in the artificial intelligence (AI) sector has led to more research and exploration in related fields, and has attracted increased investment in fields benefiting from AI advancements, including robotics and medicine.

      AI is also being used as a tool to help discover new insights and make moves that might not have been possible without its use. Scientists in California have even developed a brain implant capable of decoding and vocalizing inner speech.

      Finally, one of the simplest ways to gain exposure to Neuralink would be through an exchange-traded fund (ETF) that invests in companies related to BCI technology. While there isn’t an ETF that exclusively focuses on BCIs, there are funds that offer exposure to related themes.

      In the health sector, some options covering similar themes include medical device ETFs and the iShares Healthcare Innovation ETF (LSE:HEAL,OTCPK:BLKIF), a fund that consists of companies that are developing new and innovative healthcare technologies.

      Two other options are the Global X Robotics & Artificial Intelligence ETF (NASDAQ:BOTZ), which includes companies that are involved in the development of robotics and AI, and the ARK Innovation ETF (ARCA:ARKK), which focuses on disruptive technologies across multiple industries, including healthcare and robotics.

      As with any investment decision, it’s important to perform due diligence on available options, including comparing ETFs, to ensure they align with one’s investment goals.

      Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

      This post appeared first on investingnews.com

      NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

      Osisko Metals Incorporated (the ‘Company’ or ‘Osisko Metals’) (TSX: OM,OTC:OMZNF; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce the successful closing of its previously-announced ‘bought-deal’ private placement financing, pursuant to which the Company issued an aggregate of 11,812,000 common shares of the Company that will qualify as ‘flow-through shares’ (within the meaning of subsection 66(15) of the Income Tax Act (Canada)) (the ‘Flow-Through Shares’) at a price of C$1.27 per Flow-Through Share for gross proceeds to the Company of C$15,001,240 (the ‘Offering’).

      The Company will use an amount equal to the gross proceeds from the sale of the Flow-Through Shares under the Offering to incur eligible ‘Canadian exploration expenses’ that will qualify as ‘flow-through critical mineral mining expenditures’ (as both terms are defined in the Income Tax Act (Canada)) (the ‘Qualifying Expenditures‘), in respect of the Company’s projects in Canada. The Qualifying Expenditures will be incurred on or before December 31, 2027 and will be renounced by the Company to the initial purchasers of the Flow-Through Shares with an effective date no later than December 31, 2026.

      The Offering was co-led by Canaccord Genuity Corp. and BMO Capital Markets.

      The Company understands that Agnico Eagle Mines Limited and Hudbay Minerals Inc., two of its existing strategic investors, along with Toronto-based fund Rosseau Asset Management Ltd., have purchased, as part of a follow-on transaction to the issuance of the Flow-Through Shares, all of the Common Shares issued under the Offering at a price of C$0.85 per Common Share for an aggregate purchase price of approximately C$10 million.

      The Flow-Through Shares issued under the Offering are subject to a hold period expiring four months and one day from the date hereof, pursuant to applicable Canadian securities laws. The Offering remains subject to final acceptance of the Toronto Stock Exchange.

      This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any state securities laws and may not be offered or sold within the United States or to or for the account or benefit of a U.S. person (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

      About Osisko Metals

      Osisko Metals Incorporated is a Canadian exploration and development company creating value in the critical metals sector, with a focus on copper and zinc. The Company acquired a 100% interest in its flagship project, the past-producing Gaspé Copper mine, from Glencore Canada Corporation in July 2023. The Gaspé Copper project is located near Murdochville in Québec’s Gaspé Peninsula. The Company is currently focused on resource expansion of the Gaspé Copper system, with current Indicated Mineral Resources of 824 Mt grading 0.34% CuEq and Inferred Mineral Resources of 670 Mt grading 0.38% CuEq (in compliance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects). For more information, see Osisko Metals’ November 14, 2024 news release entitled ‘Osisko Metals Announces Significant Increase in Mineral Resource at Gaspé Copper‘. Gaspé Copper hosts the largest undeveloped copper resource in eastern North America, strategically located near existing infrastructure in the mining-friendly province of Québec.

      In addition to the Gaspé Copper project, the Company is working with Appian Capital Advisory LLP, through the Pine Point Mining Limited joint venture, to advance one of Canada’s largest past-producing zinc mining camps, the Pine Point project, located in the Northwest Territories. The current mineral resource estimate for the Pine Point project consists of Indicated Mineral Resources of 49.5 Mt at 5.52% ZnEq and Inferred Mineral Resources of 8.3 Mt at 5.64% ZnEq (in compliance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects). For more information, see Osisko Metals’ June 25, 2024 news release entitled ‘Osisko Metals releases Pine Point mineral resource estimate: 49.5 million tonnes of indicated resources at 5.52% ZnEq’. The Pine Point project is located on the south shore of Great Slave Lake, Northwest Territories, close to infrastructure, with paved road access, an electrical substation and 100 kilometers of viable haul roads.

      For further information on this news release, visit www.osiskometals.com or contact:

      Don Njegovan, President
      Email: info@osiskometals.com
      Phone: (416) 500-4129

      Cautionary Statement on Forward-Looking Information

      This news release contains ‘forward-looking information’ within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Any statement that involves predictions, expectations, interpretations, beliefs, plans projections, objectives, assumptions, future events or performance (often, but not always, using phrases such as ‘expects’ or ‘does not expect’, ‘is expected’, ‘interpreted’, ‘management’s view’, ‘anticipates’ or ‘does not anticipate’, ‘plans’, ‘budget’, ‘scheduled’, ‘forecasts’, ‘estimates’, ‘potential’, ‘feasibility’, ‘believes’ or ‘intends’ or variations of such words and phrases or stating that certain actions, events or results ‘may’ or ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. This news release contains forward-looking information pertaining to, among other things: the ability for the Company to obtain the final approval of the Toronto Stock Exchange; the anticipated use of proceeds of the Offering; the tax treatment of the Flow-Through Shares; the timing of incurring and renunciation of the Qualifying Expenditures; and the ability to advance the Company’s properties (and results thereof); and Gaspé Copper hosting the largest undeveloped copper resource in eastern North America.

      Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management, in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including, without limitation, assumptions about: general market conditions impacting the Company; the ability of exploration results, including drilling, to accurately predict mineralization; errors in geological modelling; insufficient data; equity and debt capital markets; future spot prices of copper and zinc; the timing and results of exploration and drilling programs; the accuracy of mineral resource estimates; production costs; political and regulatory stability; the receipt of governmental and third party approvals; licenses and permits being received on favourable terms; sustained labour stability; stability in financial and capital markets; and availability of mining equipment and positive relations with local communities and groups. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Such factors include, among others, risks relating to the ability of the Company to obtain required approvals, the ability of the Company to complete further exploration activities, including drilling; the results of exploration activities; risks relating to mining activities; risks relating to the global economic climate and metal prices; environmental risks; changes in tax and regulatory regimes; and community and non-governmental actions. Factors that could cause actual results to differ materially from such forward-looking information are set out in the Company’s public disclosure record on SEDAR+ (www.sedarplus.ca) under Osisko Metals’ issuer profile. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

      News Provided by GlobeNewswire via QuoteMedia

      This post appeared first on investingnews.com